ANACABIN 200 - CÔNG TY CỔ PHẦN GLOBAL PHARMACEUTICAL

ANACABIN 200 - CÔNG TY CỔ PHẦN GLOBAL PHARMACEUTICAL

ANACABIN 200 - CÔNG TY CỔ PHẦN GLOBAL PHARMACEUTICAL

ANACABIN 200 - CÔNG TY CỔ PHẦN GLOBAL PHARMACEUTICAL

global pharmaceutical

GLOBAL PHARMACEUTICAL JOINT-STOCK COMPANY

TAKE CARE OF COMMUNITY HEALTH

 global pharmaceutical
Advice and support

0981314599

ANACABIN 200
ANACABIN 200

ANACABIN 200

Present

Box of 2 blisters x 10 film-coated caplets

Ingredient

Each film-coated caplet contains: Cefditoren 200mg (As cefditoren pivoxin 245,10mg). Excipients q.s for 1 film-coated caplets

Point

Cefditoren pivoxil is indicated for the treatment of mild to moderate infections in adults and adolescents (12 years of age or older) which are caused by susceptible strains of the designated microorganisms in the conditions listed below.
   
DETAIL

ANACABIN 200

Keep out of reach of children. Read the manual carefully before use

If need more information please consult with your doctor

COMPOSITION:

Each film-coated caplet contains: Cefditoren 200mg (As cefditoren pivoxin 245,10mg).

Excipients q.s for 1 film-coated caplet

INDICATIONS AND USAGE:

Cefditoren pivoxil is indicated for the treatment of mild to moderate infections in adults and adolescents (12 years of age or older) which are caused by susceptible strains of the designated microorganisms in the conditions listed below.

Acute Bacterial Exacerbation of Chronic Bronchitis caused by Haemophilus influenzae (including ßlactamase- producing strains), Haemophilus parainfluenzae (including ß-lactamase producing strains),

Streptococcus pneumoniae (penicillin susceptible strains only), or Moraxella catarrhalis (including ßlactamase- producing strains).

Community-Acquired Pneumonia caused by Haemophilus influenzae (including ß-lactamase producing strains), Haemophilus parainfluenzae (including ß-lactamase-producing strains), Streptococcus pneumoniae (penicillin-susceptible strains only), or Moraxella catarrhalis (including ß-lactamase producing strains).

Pharyngitis /Tons illitis caused by Streptococcus pyogenes. NOTE: Cefditoren Pivoxil is effective in the eradication of Streptococcus pyogenes from the oropharynx. Cefditoren Pivoxil Tablets has not been studied for the prevention of rheumatic fever following Streptococcus pyogenes pharyngitis/tonsillitis.

Only intramuscular penicillin has been demonstrated to be effective for the prevention of rheumatic fever.

Uncomplicated Skin and Skin-Structure Infections caused by Staphylococcus aureus (including ßlactamase-producing strains) or Streptococcus pyogenes.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Cefditoren Pivoxil and other antibacterial drugs, Cefditoren Pivoxil should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

CONTRAINDICATIONS:

Cefditoren Pivoxil is contraindicated in patients with known allergy to the cephalosporin class of antibiotics or any of its components.

Cefditoren Pivoxil is contraindicated in patients with carnitine deficiency or inborn errors of metabolism that may result in clinically significant carnitine deficiency, because use of Cefditoren Pivoxil causes renal excretion of carnitine.

Cefditoren Pivoxil tablets contain sodium caseinate, a milk protein. Patients with milk protein hypersensitivity (not lactose intolerance) should not be administered Cefditoren Pivoxil.

OTHER INFORMATION: Please refer to the Instruction sheet included in the package

MANUFACTURERMEDIPHARCO JOINT-STOCK COMPANY

DISTRIBUTOR: GLOBAL PHARMACEUTICAL JOINT-STOCK COMPANY

 

OTHER PRODUCTS
HOT NEWS
SHAREHOLDERS NEWS